All In Biotech

Drug Trial Radar · NCT07076342

The Role of mGluR5 in CBT-I

Mechanistic Clinical Trial Evaluating the Role of the Metabotropic Glutamate Receptor Subtype 5 (mGluR5) in the Antidepressant Mechanism of Cognitive Behavioral Therapy for Insomnia (CBT-I)

Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

42

Planned (sponsor's estimate)

Start

Aug 1, 2025

Primary completion

Mar 31, 2030

Study completion Mar 31, 2030

Sponsor

Lead sponsor
Stony Brook UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institutes of Health (NIH); National Institute of Mental Health (NIMH)
First posted
Jul 22, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is mechanistic clinical trial that evaluates the role of one of the glutamate receptors (mGluR5) in cognitive behavioral therapy for insomnia (CBT-I) as a common pathway in improving sleep and depression.

Conditions

  • Major Depressive Disorder (MDD)

Interventions

  • Cognitive Behavioral Therapy for InsomniaBehavioral

    Cognitive Behavioral Therapy for Insomnia (CBT-I) will be delivered through an online program, Sleep Healthy Using The Internet Sleep Healthy Using The Internet (SHUTi)

  • PET Scan with [11C]ABP688Drug

    Prior to and after completing the CBT-I protocol, participants will undergo a PET scan using tracer \[11C\]ABP688) to quantify hippocampal mGluR5 density.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Sleep Latency from Baseline to 8 WeeksTime frame: Baseline and 8 Weeks
  2. Change from Baseline of mGluR5 density in the hippocampus after 8 weeks of CBT-I TreatmentTime frame: Baseline and 8 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Stony Brook University: Dept of Psychiatry

    Stony Brook, New York · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.